EADV Congress 2025
Congress coverage by Medthority
From new approaches to alopecia areata (AA) assessment to emerging agents for hidradenitis suppurativa (HS), catch up on the insights you might have missed at this year’s European Academy of Dermatology and Venereology (EADV) Congress.
Developed by EPG Health for Medthority, independently of any sponsor.
Navigating CSU: Timing and novel agents
Updates from EADV Congress 2025 on managing chronic spontaneous urticaria (CSU), including early vs late biologic use and comparative insights on advanced therapies.
Developed independently by EPG Health with an educational grant from Novartis.
Updates in your area
of interest
of interest
Articles your peers
are looking at
are looking at
Bookmarks
saved
saved
Days to your
next event
next event